Hideo Maeba

Title: Hideo Maeba: Innovator in Recombinant Beta-Amylase

Introduction

Hideo Maeba is a notable inventor based in Yaizu, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant enzymes. With a total of 2 patents, his work has garnered attention for its innovative approaches and practical applications.

Latest Patents

Maeba's latest patents focus on recombinant beta-amylase. This enzyme has been engineered to exhibit superior thermostability compared to its original counterpart. The advancements were achieved through site-directed mutagenesis of the recombinant beta-amylase gene, which encodes 531 amino acid residues. Key substitutions include replacing MET.sub.181 with Leu, Ser.sub.291 with Ala, Ile.sub.293 with Val, Ser.sub.346 with Pro, Ser.sub.347 with Pro, Gln.sub.348 with Asp, and Ala.sub.372 with Ser. These modifications enhance the enzyme's stability, making it more effective for various industrial applications.

Career Highlights

Hideo Maeba is currently associated with Sapporo Breweries Limited, where he applies his expertise in enzyme technology. His work at the company has been instrumental in advancing their product offerings and improving production processes.

Collaborations

Maeba has collaborated with notable colleagues, including Naohiro Yoshigi and Yukio Okada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hideo Maeba's contributions to the field of biotechnology, particularly through his work on recombinant beta-amylase, highlight his role as a significant inventor. His innovative approaches continue to influence the industry and pave the way for future advancements.